To date, the clinically used HCC diagnostic biomarkers include alpha-fetoprotein (AFP), Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) and des-gamma-carboxy prothrombin (DCP), but their performance are limited. This evidence concerns the gene AFP and hepatocellular carcinoma.